Skip to content
All Updates
- National Essential Medicine ListsJuly 22, 2022
- National Pharmacovigilance Center Convened one-day Training Session for Clinical / Hospital Pharmacist and Pharmacovigilance Officer at Rawalpindi Medical UniversityJuly 22, 2022
- S.R.O. 1083(I)/2022 (Maximum retail price of Remdesivir injection)July 22, 2022
- Draft amendments in rules framed under Drug Act 1976 (for comments within 7 days of publication of SRO).July 21, 2022
- Policy for Inspection of Manufacturing Site AbroadJuly 6, 2022
- DRAP notified National Pharmacovigilance Centre (NPC) under the Pharmacovigilance Rules, 2022July 6, 2022
- Minutes of 317th Meeting of Registration Board held on 16th – 17th May, 2022.June 27, 2022
- Minutes of 286th Meeting of Central Licensing Board held on 11th May 2022June 24, 2022
- DRAP notified Pharmacovigilance Risk Assessment Expert Committee (PRAEC) under the Pharmacovigilance Rules, 2022June 20, 2022
- Proposed amendments in the Rules : DRAP invites comments from stakeholders and public on the draft amendments in the Drugs (Licensing, Registering and Advertising) Rules, 1976;June 20, 2022
- National Pharmacovigilance Centre, DRAP intends to seek comments of Stakeholders on “Draft Guidelines on High Alert Medication Management”June 16, 2022
- Suspension of Drug Registration: Famotidine Liquid Suspension in the Strengths of 10mg/5mL and 40mg/mLJune 16, 2022
- Suspension of Drug Registration: Tablets of Diclofenac Potassium in Strengths of 75mg and 100mgJune 16, 2022
- Recall Alert: Drug Product; Water for Injection (Batch #M21421) by M/s. Vision Pharmaceuticals (Pvt.) Ltd., Islamabad.June 15, 2022
- Decisions of 47th meeting of Medical Device Board Meeting; Deficiency letterJune 15, 2022
- DRAP Organizes one-day Training Workshop of its officers on Key Performance Indicators (KPIs) of various Regulatory FunctionsJune 14, 2022
- Voluntary Recall Alert: Drug Product; Meronem 1g Injection (Batch #4A20B27 and Batch # 4A21D29) by M/S. Pfizer Pakistan Limited, KarachiJune 2, 2022
- Partial Minutes of 317th Meeting of Registration BoardMay 31, 2022
- Deficiency Deferred Letters 104th,105th And 106th Meeting of EECMay 31, 2022
- DRAP invites comments of stakeholders on the draft Guidelines on Good Distribution Practices for Pharmaceutical and Biological ProductsMay 28, 2022
- Holding of Khuli E-KachehriMay 23, 2022
- National Pharmacovigilance Centre, DRAP holds one-day training session for Healthcare Professionals in collaboration with regional centre.May 20, 2022
- S.R.O.559(I)/2022 (Amendments in the Medical Devices Rules, 2017)May 18, 2022
- Stakeholder Comments are invited on draft guidance for Categorization of deficiencies in Good Manufacturing Practices (GMP)May 18, 2022
- DRAP issued Guidelines for Public Health Programs (PHPs) to promote Pharmacovigilance activities and enhancing collaboration with National Pharmacovigilance Centre, DRAP.May 16, 2022
- Minutes of 316th Meeting of Registration Board held on 15th to 18th March, 2022May 14, 2022
- Invitation to Bid: Purchase & Deployment of Endpoint Security / Antivirus SoftwareMay 14, 2022
- DRAP issues guidance on the submissions of Clinical Trials ApplicationsMay 12, 2022
- Minutes of 285th Meeting of Central Licensing Board held on 17-18th March 2022April 28, 2022
- DRAP issues final Guidance document for applicants on Import and Export permissions of therapeutic goods in the countryApril 27, 2022
- Mr. Asim Rauf, CEO, DRAP met with WHO Country Representative, Dr Palitha Gunarathna Mahipala to promote bilateral cooperationApril 27, 2022
- DRAP notified the Pharmacovigilance Rules, 2022, for active monitoring of safety of therapeutic goods across the countryApril 26, 2022
- National Pharmacovigilance Centre, DRAP issued draft guidelines on promoting Pharmacovigilance activities in Public Health Programs (PHPs).April 23, 2022
- Drug Product Recall: Water for Injection (Batch # 826) by M/s. Zafa Pharmaceutical Laboratories Pvt Ltd, Karachi.April 21, 2022
- DRAP issues a guidance for Healthcare Professionals on reporting of Adverse Events to the Pharmacovigilance CentersApril 15, 2022
- DRAP asks stakeholders to comment on the draft guidelines on Bio-availability & Bio-equivalence studies for generic drug productsApril 15, 2022
- Stakeholders comments are invited on draft Guidelines for Labeling & Packaging of finished drug products.April 15, 2022
- DRAP seeks comments of stakeholders on draft guidance document for Clinical Trials ApplicantsApril 8, 2022
- Drug Product Recall; Flagynase Suspension (Batch # 0244) by M/s. Aries Pharmaceuticals Pvt. Ltd, Peshawar.April 8, 2022
- DRAP issues guidelines on Good Pharmacovigilance Practices for Product Registration HoldersApril 7, 2022
- Circular: Mecobalamin Manufacturing and TestingApril 5, 2022
- Circular: Cefixime Capsule 200mg & 400mg Specifications.April 5, 2022
- DRAP holds meeting of provincials’ health departments and drug control organizations of all federating units to strengthen the regulatory oversight through an integrated and harmonized regulatory approach.April 1, 2022
- Drug Product Recall; Water for Injection (Batch#LI-961) by M/s Safe Pharmaceuticals Pvt. Ltd., KarachiMarch 29, 2022
- S.R.O. 430(I)/2022 (Notification of Amendments in Form 6A and Form 7A of the Medical Devices Rules, 2017 (18.03.2022))March 29, 2022
- HOLDING OF KHULI E-KACHEHRIMarch 18, 2022
- Notification of Draft Amendments in Schedule D-1 of the Drugs (L,R&A) Rules, 1976March 18, 2022
- Drug Product Recall: Sodium Chloride 0.9% INFUSION (Batch#A060E21) by M/s. Otsuka Pakistan Limited, Hub.March 15, 2022
- Promotion and Growth of Active Pharmaceutical Ingredient (API) Industry in PakistanMarch 15, 2022
- SRO 406(I)/2022 (Reduction in MRP of Remdesivir 100mg injection)March 10, 2022